U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details

Fenofibrate

Last Revision: June 21, 2021.

CASRN: 49562-28-9

image 135000744 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

No relevant published information exists on the use of fenofibrate during breastfeeding. Because of a concern with disruption of infant lipid metabolism, fenofibrate is best avoided during breastfeeding. An alternate drug is preferred, especially while nursing a newborn or preterm infant. The manufacturer recommends that breastfeeding be avoided during fenofibrate therapy and for 5 days after the final dose.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Cholestyramine, Colesevelam, Colestipol

Substance Identification

Substance Name

Fenofibrate

CAS Registry Number

49562-28-9

Drug Class

Breast Feeding

Lactation

Anticholesteremic Agents

Antilipemic Agents

Fibric Acids

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK501636PMID: 30000697

Views

Related information

Similar articles in PubMed

  • Review Ethacrynic Acid.[Drugs and Lactation Database (...]
    Review Ethacrynic Acid.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Gemfibrozil.[Drugs and Lactation Database (...]
    Review Gemfibrozil.
    . Drugs and Lactation Database (LactMed®). 2006
  • Lipid-lowering drugs.[Med Lett Drugs Ther. 2019]
    Lipid-lowering drugs.
    . Med Lett Drugs Ther. 2019 Feb 11; 61(1565):17-24.
  • Comparison table: Some lipid-lowering drugs.[Med Lett Drugs Ther. 2022]
    Comparison table: Some lipid-lowering drugs.
    . Med Lett Drugs Ther. 2022 Sep 19; 64(1659):e152-e158. Epub 2022 Sep 19.
  • Review Carisoprodol.[Drugs and Lactation Database (...]
    Review Carisoprodol.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...